David Eidelberg

Abnormal metabolic brain networks in Parkinson's disease from blackboard to bedside.

Can imaging distinguish PSP from other neurodegenerative disorders?

Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease.

Modulation of regional brain function by deep brain stimulation: studies with positron emission tomography.

Pallidal stimulation for parkinsonism: improved brain activation during sequence learning.

Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach.

Dyskinesia after fetal cell transplantation for parkinsonism: a PET study.

Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression.

Functional brain imaging in Parkinson's disease.

Primary dystonia: is abnormal functional brain architecture linked to genotype?

Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.

Chemotherapy-induced parkinsonism responsive to levodopa: an underrecognized entity.

The differential effect of PD and normal aging on early explicit sequence learning.

Dosimetry of the dopamine transporter radioligand 18F-FPCIT in human subjects.

Learning networks in health and Parkinson's disease: reproducibility and treatment effects.

Impaired sequence learning in carriers of the DYT1 dystonia mutation.

Brain networks and clinical penetrance: lessons from hyperkinetic movement disorders.

Abnormal brain networks in primary torsion dystonia.

Quantitative Brain PET. Comparison of 2D and 3D Acquisitions on the GE Advance Scanner.

Differential cortical and subcortical activations in learning rotations and gains for reaching: a PET study.

Evolving metabolic changes during the first postoperative year after subthalamotomy.

Early stage Parkinson's disease patients and normal volunteers: comparative mechanisms of sequence learning.

Radiosynthesis of [18F] N-(3-Fluoropropyl)-2-beta-Carbomethoxy-3-beta-(4-Bromophenyl) Nortropane and the regional brain uptake in non human primate using PET.

Serotonin modulation of cerebral glucose metabolism in normal aging.

Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics.

Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.

The role of functional neuroimaging in the differential diagnosis of idiopathic Parkinson's disease and multiple system atrophy.

The metabolic topography of posthypoxic myoclonus.

Preoperative response to levodopa is the best predictor of transplant outcome.

Executive processes in Parkinson's disease: FDG-PET and network analysis.

Microstructural white matter changes in carriers of the DYT1 gene mutation.

Woman with a 26-year history of parkinsonism, supranuclear ophthalmoplegia, and loss of postural reflexes.

Effects of serotonin transporter promoter polymorphisms on serotonin function.

Assessment of disease progression in parkinsonism.

The metabolic pathology of dopa-responsive dystonia.

Neuroimaging and therapeutics in movement disorders.

A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis.

Anticholinesterase effect on motor kinematic measures and brain activation in Parkinson's disease.

Preclinical Huntington's disease: compensatory brain responses during learning.

Neuroimaging in human dystonia.

Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease.

Functional imaging of sequence learning in Parkinson's disease.

Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.

Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT.

Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism.

An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease.

Network modulation in the treatment of Parkinson's disease.

The assessment of neurological systems with functional imaging.

L-Dopa infusion does not improve explicit sequence learning in Parkinson's disease.

Correlates of movement initiation and velocity in Parkinson's disease: A longitudinal PET study.

Quantification of Parkinson's disease-related network expression with ECD SPECT.

Metabolic brain networks associated with cognitive function in Parkinson's disease.

Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging.

Testing a test for Alzheimer disease.

Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease.

Gene transfer therapy for neurodegenerative disorders.

Changes in network activity with the progression of Parkinson's disease.

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.

Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease.

Assessment of the progression of Parkinson's disease: a metabolic network approach.

Increased cerebellar activation during sequence learning in DYT1 carriers: an equiperformance study.

Microstructural white matter changes in primary torsion dystonia.

New strategies for automated differential diagnosis of degenerative brain disorders.

Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease.

Abnormal metabolic networks in atypical parkinsonism.

Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography.

Metabolic correlates of subthalamic nucleus activity in Parkinson's disease.

Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease.

Learning and consolidation of visuo-motor adaptation in Parkinson's disease.

Dopaminergic suppression of brain deactivation responses during sequence learning.

Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography.

Re-emergent tremor without accompanying rest tremor in Parkinson's disease.

Abnormal regional brain function in Parkinson's disease: truth or fiction?

Network biomarkers for the diagnosis and treatment of movement disorders.

Seizure propagation in a patient with musicogenic epilepsy.

Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.

The functional neuroanatomy of geriatric depression.

Mom and me: brain metabolism links Alzheimer disease to maternal genes.

Assessing the microlesion effect of subthalamic deep brain stimulation surgery with FDG PET.

Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features.

Serotonin modulation of cerebral glucose metabolism in depressed older adults.

Positron emission tomography imaging.

Cerebellothalamocortical connectivity regulates penetrance in dystonia.

Metabolic brain networks in neurodegenerative disorders: a functional imaging approach.

Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease.

Early Parkinson's disease: longitudinal changes in brain activity during sequence learning.

Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes.

Parkinson's disease spatial covariance pattern: noninvasive quantification with perfusion MRI.

Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis.

Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease.

Increased sensorimotor network activity in DYT1 dystonia: a functional imaging study.

Imaging essential tremor.

Increased reaction time predicts visual learning deficits in Parkinson's disease.

FDG PET in the Evaluation of Parkinson's Disease.

Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects.

Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression.

Hereditary dystonia as a neurodevelopmental circuit disorder: Evidence from neuroimaging.

Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues.

Three-fold cross-validation of parkinsonian brain patterns.

The relationship between the acute cerebral metabolic response to citalopram and chronic citalopram treatment outcome.

Brain networks in Huntington disease.

Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice.

Impaired sequence learning in dystonia mutation carriers: a genotypic effect.

Milestones in neuroimaging.

Basal ganglia and kinematics modulation: insights from Parkinson's and Huntington's diseases.

Dopamine cell transplantation in Parkinson's disease: challenge and perspective.

Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with Systemic Lupus Erythematosus stratified by disease duration.

Therapeutic high-frequency stimulation of the subthalamic nucleus in Parkinson's disease produces global increases in cerebral blood flow.

Using imaging to identify psychogenic parkinsonism before deep brain stimulation surgery. Report of 2 cases.

Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism.

Functional brain networks and abnormal connectivity in the movement disorders.

To scan or not to scan: DaT is the question.

Improved sequence learning with subthalamic nucleus deep brain stimulation: evidence for treatment-specific network modulation.

Functional neuroimaging in Parkinson's disease.

Functional brain networks in movement disorders: recent advances.

Longitudinal studies of cerebral glucose metabolism in late-life depression and normal aging.

Correlation of laparoscopic experience with differential functional brain activation: a positron emission tomography study with oxygen 15-labeled water.

Functional brain imaging of cognitive dysfunction in Parkinson's disease.

Serotonin modulation of cerebral glucose metabolism: sex and age effects.

Metabolic brain networks in translational neurology: concepts and applications.

Abnormal network topographies and changes in global activity: absence of a causal relationship.

White matter changes in primary dystonia determined by 2D distribution analysis of diffusion tensor images.

Early registration of diffusion tensor images for group tractography of dystonia patients.

Metabolic changes in DYT11 myoclonus-dystonia.

Metabolic imaging of bilateral anterior capsulotomy in refractory obsessive compulsive disorder: an FDG PET study.

Parkinson's disease: increased motor network activity in the absence of movement.

Parkinson's disease cognitive network correlates with caudate dopamine.

Characterization of disease-related covariance topographies with SSMPCA toolbox: Effects of spatial normalization and PET scanners.